This bill names a U.S. Postal Service facility at 1300 East Northwest Highway in Palatine, Illinois, as the "Bernie Bluestein Post Office Building." It updates all official references in federal laws, documents, and records to reflect this new name for the location. The change is purely administrative and affects how the building is identified in government materials. No new policies or funding are involved; it is a ceremonial designation.
Skills-Based Federal Contracting Act This bill prohibits federal contract bid solicitations for contractor personnel from including minimum educational requirements unless the contracting officer justifies the requirements. The prohibition applies to educational requirements that may be met through education alone, education or experience, or a combination of education and experience. The bill also requires the Office of Management and Budget to issue implementing guidance to federal agencies, including instructions for contracting officers that encourage using alternatives to education requirements.
HR 2466 designates the U.S. Postal Service facility at 5225 Harrison Avenue in Rockford, Illinois, as the "Jay P. Larson Post Office Building." The bill updates all federal references - including laws, maps, and official documents - to use this new name for the building. It does not create new policies or affect residents, businesses, or postal services. This is a ceremonial naming bill with no financial or operational changes.
This resolution designates August 1, 2026, as Gold Star Children's Day to honor the sacrifices and hardships faced by children of fallen members of the U.S. Armed Forces. The bill does not create new laws or change government operations; instead, it serves as a formal expression of gratitude from the Senate and encourages the public to observe this day in support of these families. By establishing this specific date, the measure aims to raise awareness about the legacy carried by children who lost a parent in military service.
This resolution designates the week of August 2 through August 8, 2026, as "National Farmers Market Week" to honor the importance of local food markets. It serves as a symbolic gesture to recognize how these markets support farmers' livelihoods, strengthen local economies, and connect urban and rural communities. The bill does not create new laws or funding but instead formally acknowledges the role farmers markets play in promoting sustainable farming and public health.
This resolution designates July 30, 2026, as "National Whistleblower Appreciation Day" to honor individuals who report misconduct, fraud, or abuse within the government. It requires federal agencies to inform employees, contractors, and the public about the legal protections available for reporting wrongdoing and to acknowledge the contributions whistleblowers make to saving taxpayer money. The bill does not create new laws or penalties but serves as a commemorative measure to encourage ethical reporting and recognize the role of whistleblowers in maintaining an ethical government.
Gateway Partnership Act This bill authorizes the National Park Service (NPS) to enter into a one-time agreement with the Gateway Arch Park Foundation to host private events at the Gateway Arch National Park and its buildings for a period of up to five years. The NPS manages the park, located in St. Louis, Missouri, and its buildings, such as the Arch Visitor Center and the Old Courthouse. The bill outlines the terms and conditions that must be included in the agreement. The bill also requires private events hosted at the park or its buildings to be consistent with the park's purposes and compatible with NPS programs. Such events may not (1) degrade the integrity, appearance, or purposes of the park; or (2) take place during times or in locations that prevent or disrupt public use or access to the park or its buildings. The NPS must charge a fee to cover the cost of wear and tear resulting from the private events. The NPS may recover all costs incurred as a result of the private events, including maintenance, utilities, administrative expenses, security, and personnel costs. The bill terminates the NPS's authority to enter and carry out an agreement with the foundation seven years after the enactment of this bill.
This concurrent resolution directs the President to withdraw United States Armed Forces from any hostilities against Iran. It specifically invokes the War Powers Resolution, mandating this removal unless Congress formally declares war or provides specific authorization for military force against Iran. The bill clarifies that it does not prevent the U.S. from acting in self-defense, maintaining a defensive troop presence in the region, or continuing intelligence activities related to threats from Iran.
This bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.
This bill limits how many patents brand-name drug companies can use to block generic versions of biological drugs (biologics). It caps the number of patents a brand company can assert in lawsuits against generic manufacturers at 20, with no more than 10 being patents issued after a specified date. Courts may allow more patents only in specific cases, such as if the generic company fails to provide required information or if there are material changes to the product. The law applies to new applications submitted after enactment and aims to reduce patent-related delays for cheaper generic biologics.
The NIH IMPROVE Act (HR 6238) establishes a new NIH research initiative focused on improving maternal health outcomes in the U.S. It directly affects pregnant and postpartum women, particularly those in communities experiencing health disparities linked to higher maternal mortality and severe maternal morbidity. The bill authorizes $73.4 million annually (2026-2031) for NIH to fund research targeting preventable causes of maternal deaths, reduce health disparities, and evaluate community-based interventions. Key provisions require NIH to advance evidence-based solutions through grants and studies on biological, behavioral, and regional factors affecting maternal health before, during, and after pregnancy.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
